PortfoliosLab logoPortfoliosLab logo
FSLR vs. GMED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FSLR vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Solar, Inc. (FSLR) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FSLR achieves a -12.79% return, which is significantly lower than GMED's -10.54% return. Over the past 10 years, FSLR has outperformed GMED with an annualized return of 17.10%, while GMED has yielded a comparatively lower 12.07% annualized return.


FSLR

1D
-0.29%
1M
-15.98%
6M
-4.54%
YTD
-12.79%
1Y
40.25%
3Y*
6.31%
5Y*
19.74%
10Y*
17.10%

GMED

1D
1.92%
1M
-2.99%
6M
-17.32%
YTD
-10.54%
1Y
36.75%
3Y*
8.91%
5Y*
-0.63%
10Y*
12.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FSLR vs. GMED - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FSLR
First Solar, Inc.
-12.79%48.22%2.30%15.01%71.86%-11.89%76.77%31.81%-37.12%110.41%
GMED
Globus Medical, Inc.
-10.54%5.56%55.21%-28.25%2.87%10.70%10.77%36.04%5.30%65.66%

Correlation

The correlation between FSLR and GMED is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Aug 3, 2012

0.25

The correlation between FSLR and GMED shifts across timeframes, from 0.14 (1 year) to 0.26 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

FSLR:

$24.48B

GMED:

$10.53B

EPS

FSLR:

$15.48

GMED:

$4.28

PE Ratio

FSLR:

14.72

GMED:

18.23

PEG Ratio

FSLR:

0.35

GMED:

0.19

PS Ratio

FSLR:

4.52

GMED:

3.45

PB Ratio

FSLR:

2.48

GMED:

2.28

Total Revenue (TTM)

FSLR:

$5.42B

GMED:

$3.10B

Gross Profit (TTM)

FSLR:

$2.26B

GMED:

$1.58B

EBITDA (TTM)

FSLR:

$2.15B

GMED:

$803.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FSLR vs. GMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FSLR
FSLR Risk / Return Rank: 6767
Overall Rank
FSLR Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
FSLR Sortino Ratio Rank: 6767
Sortino Ratio Rank
FSLR Omega Ratio Rank: 6666
Omega Ratio Rank
FSLR Calmar Ratio Rank: 6868
Calmar Ratio Rank
FSLR Martin Ratio Rank: 6666
Martin Ratio Rank

GMED
GMED Risk / Return Rank: 7373
Overall Rank
GMED Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
GMED Sortino Ratio Rank: 7575
Sortino Ratio Rank
GMED Omega Ratio Rank: 7272
Omega Ratio Rank
GMED Calmar Ratio Rank: 7575
Calmar Ratio Rank
GMED Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FSLR vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Solar, Inc. (FSLR) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FSLRGMEDDifference
Sharpe ratioReturn per unit of total volatility

-0.01

Sortino ratioReturn per unit of downside risk

-0.42

Omega ratioGain probability vs. loss probability

1.17

1.21

-0.04

Calmar ratioReturn relative to maximum drawdown

1.09

1.60

-0.51

Martin ratioReturn relative to average drawdown

2.17

3.87

-1.69

FSLR vs. GMED - Sharpe Ratio Comparison

The current FSLR Sharpe Ratio is 0.71, which is comparable to the GMED Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of FSLR and GMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FSLR vs. GMED - Drawdown Comparison

The maximum FSLR drawdown since its inception was -96.22%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for FSLR and GMED.


Loading charts...

Drawdown Indicators


FSLRGMEDDifference

Max Drawdown

Largest peak-to-trough decline

-96.22%

-47.91%

-48.31%

Max Drawdown (1Y)

Largest decline over 1 year

-35.10%

-22.10%

-13.00%

Max Drawdown (3Y)

Largest decline over 3 years

-59.97%

-44.40%

-15.57%

Max Drawdown (5Y)

Largest decline over 5 years

-59.97%

-47.91%

-12.06%

Max Drawdown (10Y)

Largest decline over 10 years

-61.26%

-47.91%

-13.35%

Current Drawdown

Current decline from peak

-28.41%

-19.32%

-9.09%

Average Drawdown

Average peak-to-trough decline

-63.05%

-15.33%

-47.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.53%

9.13%

+8.40%

Volatility

FSLR vs. GMED - Volatility Comparison

First Solar, Inc. (FSLR) has a higher volatility of 15.11% compared to Globus Medical, Inc. (GMED) at 13.69%. This indicates that FSLR's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FSLRGMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.11%

13.69%

+1.42%

Volatility (6M)

Calculated over the trailing 6-month period

39.86%

25.33%

+14.53%

Volatility (1Y)

Calculated over the trailing 1-year period

54.00%

49.46%

+4.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.12%

38.27%

+15.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

50.78%

35.68%

+15.10%

Dividends

FSLR vs. GMED - Dividend Comparison

Neither FSLR nor GMED has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

FSLR vs. GMED - Financials Comparison

This section allows you to compare key financial metrics between First Solar, Inc. and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
1.04B
759.85M
(FSLR) Total Revenue
(GMED) Total Revenue
Values in USD except per share items

FSLR vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between First Solar, Inc. and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
46.6%
0
Portfolio components
FSLR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, First Solar, Inc. reported a gross profit of 486.13M and revenue of 1.04B. Therefore, the gross margin over that period was 46.6%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

FSLR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, First Solar, Inc. reported an operating income of 345.30M and revenue of 1.04B, resulting in an operating margin of 33.1%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

FSLR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, First Solar, Inc. reported a net income of 346.62M and revenue of 1.04B, resulting in a net margin of 33.2%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.


Frequently Asked Questions


FSLR and GMED have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FSLR has higher volatility (15.11%) compared to GMED (13.69%). In terms of maximum drawdown, FSLR dropped -96.22% vs GMED's -47.91%.

GMED currently has the higher Sharpe Ratio (0.71 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FSLR and GMED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer